Metabolism, pharmacokinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters
- 30 April 1995
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 108 (4), 1204-1214
- https://doi.org/10.1016/0016-5085(95)90221-x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Primary Biliary Cirrhosis: New Therapeutic DirectionsScandinavian Journal of Gastroenterology, 1992
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- Nonsurgical Treatment of Gallstone DiseaseAnnual Review of Medicine, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989
- 23-Methyl-3α, 7β-dihydroxy-5β-cholan-24-oic acid: Dose-response study of biliary secretion in ratHepatology, 1988
- The Lancet, 1987
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: A comparative randomized studyHepatology, 1982
- Ursodeoxycholic acid in the treatment of cholesterol cholelithiasisDigestive Diseases and Sciences, 1982
- pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena.Journal of Lipid Research, 1980